A 26-year-old female is brought to the emergency department while having an asthma attack. She is given a nebulizer treatment with the medication albuterol. The nurse's immediate assessment priority would be to
Determine the time of the patient's last meal.
Monitor the patient's temperature and blood pressure.
Monitor respiratory rate and Spo2 with a pulse oximeter.
Provide education on asthma management and treatment.
The Correct Answer is C
During an asthma attack, the primary concern is the patient's ability to breathe and maintain adequate oxygenation. Monitoring the patient's respiratory rate and oxygen saturation (SpO2) with a pulse oximeter provides crucial information about the effectiveness of the albuterol treatment and the patient's respiratory status. It helps determine if the airway is opening up, if oxygen levels are improving, and if the patient is responding positively to the medication.
While determining the time of the patient's last meal can be relevant for certain interventions, it is not the immediate priority during an asthma attack. It is more important to focus on assessing and managing the patient's breathing and oxygenation first.
Monitoring the patient's temperature and blood pressure can be important for a comprehensive assessment, but they are not the immediate priority during an acute asthma attack. Addressing the patient's respiratory distress takes precedence.
Providing education on asthma management and treatment is an important aspect of care, but it should be done after the patient's acute symptoms are addressed and stabilized. In the immediate assessment phase, the focus is on assessing and managing the patient's respiratory status. Education can be provided once the patient's immediate needs are addressed.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Robitussin A-C contains codeine, which is an opioid antitussive that can have sedating effects. One of the major disadvantages of using this medication is the potential for drowsiness as a side effect. This can impair the client's ability to perform tasks that require alertness and can interfere with daily activities.
The other options listed are not the major disadvantage of antitussive therapy with Robitussin A-C:
The medication is irritating to the bronchial tree: Robitussin A-C is primarily used as an antitussive (cough suppressant) rather than for its effects on the bronchial tree. While it may have some mild irritant properties due to certain ingredients, it is not considered a major disadvantage of this medication.
The client may use the medication for 14 days: The duration of use for Robitussin A-C is typically determined by the healthcare provider based on the client's condition. While prolonged use of antitussives is generally not recommended without medical supervision, the duration of use is not considered the major disadvantage of this medication.
The medication is very expensive: The cost of medication can vary, and while cost may be a consideration for some individuals, it is not considered the major disadvantage of Robitussin
A-C specifically. The major disadvantage relates more to the potential for drowsiness caused by the medication.
Correct Answer is C
Explanation
Montelukast is a leukotriene receptor antagonist commonly used to manage asthma and allergic rhinitis. Its primary therapeutic effect is to improve respiratory symptoms by reducing inflammation and constriction of the airways. Therefore, an increased ease of breathing would be an expected outcome indicating that the medication is working effectively.
The other options are incorrect because:
A. The client's seizure threshold is reduced: Montelukast does not have any effect on the seizure threshold. This outcome is unrelated to the medication and may be indicative of a different condition or treatment.
B. The client experiences less muscle pain: Montelukast is not indicated for reducing muscle pain. This outcome is unrelated to the medication and may be indicative of a different condition or treatment.
D. The client's platelet count is increased: Montelukast does not have an effect on platelet count. This outcome is unrelated to the medication and may be indicative of a different condition or treatment.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.